BenevolentAI
multiple value inflection milestones expected | BenevolentAI
Company
Deck Type
Sector
Industry
Deck date
June 2022
Slide
18 of 19
Similar slides by BenevolentAI
See diffirences between slides (animation)
SPAC
December 2021
late ben atopic dermatitis phase i part a completes phase i part tes asset ready for out licensing ben ulcerative colitis candidate nominated for enabling studies reg tox completed phase i starts early collaboration in new targets selected by and further targets selected and advanced pipeline depth and progression programmes named chemistry and beyond new targets added to the pipeline per year from up to assets enter enabling studies onwards platform collaborations exploratory discussions with numerous parties underway but timing unclear multiple value in milestones in the near future late ben atopic dermatitis ben ulcerative colitis collaboration pipeline depth and progression other platform collaborations inflection | BenevolentAI
Related slides by other companies
Kymera
Investor Day
December 2021
targeting degrader advantage clinical validation and human genetics risking | Kymera
Kymera
Investor Presentation
December 2023
degrading best approach to block driven inflammation degrader advantage | Kymera
BioNTech
Results
August 2022
pursuing multiple novel covid vaccine approaches to provide durable and high level protection against evolving variants | BioNTech
Kymera
Results
December 2022
degrading degrader advantage | Kymera
Other recent decks by BenevolentAI
See all presentations (10 decks)
Results
March 2024
Investor Conference
January 2024
Investor Presentation
May 2023
Results
March 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io